Literature DB >> 21792213

Dietary intake associated with serum versus urinary carboxymethyl-lysine, a major advanced glycation end product, in adults: the Energetics Study.

R D Semba1, A Ang, S Talegawkar, C Crasto, M Dalal, P Jardack, M G Traber, L Ferrucci, L Arab.   

Abstract

BACKGROUND/
OBJECTIVES: Advanced glycation end products (AGEs) are implicated in the pathogenesis of atherosclerosis, diabetes and kidney disease. The objective was to describe dietary intake, the dominant source of exposure to AGEs, with carboxymethyl-lysine (CML), a major AGE, in serum and urine, respectively. SUBJECTS/
METHODS: Serum and urinary CML were measured in 261 adults, aged 21-69 years, and compared with diet as assessed by six separate 24-h dietary recalls.
RESULTS: Median (25th, 75th percentile) serum and urinary CML concentrations were 686 (598, 803) μg/l and 1023 (812, 1238) μg/gm creatinine. There was no correlation between serum and urinary CML (r=-0.02, P=0.78). Serum CML was positively correlated with intake of soy, fruit juice, cold breakfast cereal, non-fat milk, whole grains, fruit, non-starchy vegetables and legumes, and negatively correlated with intake of red meat. Intake of fast food was not significantly correlated with serum CML. Urinary CML was positively correlated with intake of starchy vegetables, whole grains, sweets, nuts/seeds and chicken, and negatively correlated with intake of fast foods. Intake of AGE-rich foods such as fried chicken, French fries, bacon/sausage and crispy snacks were not significantly correlated with serum or urinary CML, except for a significant negative correlation between fried chicken and serum CML.
CONCLUSIONS: These findings suggest that the high consumption of foods considered high in CML is not a major determinant of either serum or urinary CML. Further work is needed to understand the relationship of AGEs in blood and urine with the metabolism of dietary AGEs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21792213      PMCID: PMC3486696          DOI: 10.1038/ejcn.2011.139

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  26 in total

1.  Plasma levels of advanced glycation end products in healthy, long-term vegetarians and subjects on a western mixed diet.

Authors:  K Sebeková; M Krajcoviová-Kudlácková; R Schinzel; V Faist; J Klvanová; A Heidland
Journal:  Eur J Nutr       Date:  2001-12       Impact factor: 5.614

2.  Determination of creatinine by the Jaffé reaction.

Authors:  G R HERVEY
Journal:  Nature       Date:  1953-06-20       Impact factor: 49.962

3.  Studies on absorption and elimination of dietary maillard reaction products.

Authors:  Anke Förster; Yvonne Kühne; Thomas Henle
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

4.  Relationship of a dominant advanced glycation end product, serum carboxymethyl-lysine, and abnormal glucose metabolism in adults: the Baltimore Longitudinal Study of Aging.

Authors:  R D Semba; J Beck; K Sun; J M Egan; O D Carlson; R Varadhan; L Ferrucci
Journal:  J Nutr Health Aging       Date:  2010-08       Impact factor: 4.075

5.  Assay of advanced glycation endproducts in selected beverages and food by liquid chromatography with tandem mass spectrometric detection.

Authors:  Naila Ahmed; Bahar Mirshekar-Syahkal; Lauren Kennish; Nikolaos Karachalias; Roya Babaei-Jadidi; Paul J Thornalley
Journal:  Mol Nutr Food Res       Date:  2005-07       Impact factor: 5.914

6.  Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients.

Authors:  Xiaohong Zhang; Matthias Frischmann; Rose Kientsch-Engel; Katharina Steinmann; Helga Stopper; Toshimitsu Niwa; Monika Pischetsrieder
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

7.  Effectiveness of the US Department of Agriculture 5-step multiple-pass method in assessing food intake in obese and nonobese women.

Authors:  Joan M Conway; Linda A Ingwersen; Bryan T Vinyard; Alanna J Moshfegh
Journal:  Am J Clin Nutr       Date:  2003-05       Impact factor: 7.045

Review 8.  Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on "a puzzle nearing resolution".

Authors:  Vincent M Monnier; Georgian T Mustata; Klaus L Biemel; Oliver Reihl; Marcus O Lederer; Dai Zhenyu; David R Sell
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

9.  Elevated serum levels of N(epsilon)-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema.

Authors:  B O Boehm; S Schilling; S Rosinger; G E Lang; G K Lang; R Kientsch-Engel; P Stahl
Journal:  Diabetologia       Date:  2004-07-17       Impact factor: 10.122

10.  Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients.

Authors:  Jaime Uribarri; Melpomeni Peppa; Wejing Cai; Teresia Goldberg; Min Lu; Suresh Baliga; Joseph A Vassalotti; Helen Vlassara
Journal:  Am J Kidney Dis       Date:  2003-09       Impact factor: 8.860

View more
  23 in total

Review 1.  Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions.

Authors:  Remi Neviere; Yichi Yu; Lei Wang; Frederic Tessier; Eric Boulanger
Journal:  Glycoconj J       Date:  2016-06-08       Impact factor: 2.916

2.  Serum carboxymethyl-lysine, disability, and frailty in older persons: the Cardiovascular Health Study.

Authors:  Heather E Whitson; Alice M Arnold; Laura M Yee; Kenneth J Mukamal; Jorge R Kizer; Luc Djousse; Joachim H Ix; David Siscovick; Russell P Tracy; Stephen M Thielke; Calvin Hirsch; Anne B Newman; Susan Zieman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-10-14       Impact factor: 6.053

3.  Perspective: The Paradox in Dietary Advanced Glycation End Products Research-The Source of the Serum and Urinary Advanced Glycation End Products Is the Intestines, Not the Food.

Authors:  Luanne R DeChristopher
Journal:  Adv Nutr       Date:  2017-09-15       Impact factor: 8.701

4.  Contribution of dietary advanced glycation end products (AGE) to circulating AGE: role of dietary fat.

Authors:  Kathleen E Davis; Chandan Prasad; Parakat Vijayagopal; Shanil Juma; Beverley Adams-Huet; Victorine Imrhan
Journal:  Br J Nutr       Date:  2015-09-22       Impact factor: 3.718

Review 5.  AGE-RAGE Stress, Stressors, and Antistressors in Health and Disease.

Authors:  Kailash Prasad; Manish Mishra
Journal:  Int J Angiol       Date:  2017-12-28

6.  Serum carboxymethyllysine, an advanced glycation end product, and age-related macular degeneration: the Age, Gene/Environment Susceptibility-Reykjavik Study.

Authors:  Richard D Semba; Mary Frances Cotch; Vilmundur Gudnason; Gudny Eiríksdottir; Tamara B Harris; Kai Sun; Ronald Klein; Fridbert Jonasson; Luigi Ferrucci; Debra A Schaumberg
Journal:  JAMA Ophthalmol       Date:  2014-04-01       Impact factor: 7.389

7.  Soluble receptor for advanced glycation end products and risk of liver cancer.

Authors:  Kristin A Moy; Li Jiao; Neal D Freedman; Stephanie J Weinstein; Rashmi Sinha; Jarmo Virtamo; Demetrius Albanes; Rachael Z Stolzenberg-Solomon
Journal:  Hepatology       Date:  2013-05-14       Impact factor: 17.425

8.  Serum carboxymethyl-lysine, an advanced glycation end product, is associated with arterial stiffness in older adults.

Authors:  Richard D Semba; Kai Sun; Ann V Schwartz; Ravi Varadhan; Tamara B Harris; Suzanne Satterfield; Melissa Garcia; Luigi Ferrucci; Anne B Newman
Journal:  J Hypertens       Date:  2015-04       Impact factor: 4.844

9.  Dietary Advanced Glycation End-products (AGE) and Risk of Breast Cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO).

Authors:  Omonefe O Omofuma; David P Turner; Lindsay L Peterson; Anwar T Merchant; Jiajia Zhang; Susan E Steck
Journal:  Cancer Prev Res (Phila)       Date:  2020-03-13

10.  Biodistribution and elimination study of fluorine-18 labeled Nε-carboxymethyl-lysine following intragastric and intravenous administration.

Authors:  Hongzeng Xu; Zhongqun Wang; Yan Wang; Shengda Hu; Naifeng Liu
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.